Projects per year
Personal profile
Education
- 2002 Ph.D. National Taiwan University
- 1994 M.S. Taipei Medical University
Experience
- 2023- Dean, College of Medical Science and Technology, Taipei Medical University
- 2020-2023 Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2019-2022 Director, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2017- Professor, Ph.D. Program in Biotechnology Research and Development, , Taipei Medical University
- 2016-2018 Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2016 Associate Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2008-2013 Assistant Professor, Department of Pharmacology, Taipei Medical University
- 2009-2013 Assistant Investigator, National Health Research Institutes
- 2007-2009 Assistant Investigator, National Taiwan University
- 2002-2007 Postdoctor, National Taiwan Universiy
- 1994-1998 Teaching Assistant, Chang-Gung University
Awards
- 2019 Single Research Project Budget Award, Taipei Medical University
Research Interests
- Drug Discovery
- Disease animal model
- Pharmacology
Related Link
Fingerprint
- 1 Similar Profiles
Network
-
112年度【臨床前藥物研發人工智慧平台】
1/1/23 → 12/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
111 年「教育部補助大專校院 STEM 領域及女性研發人才培育計畫」:整合智慧型新藥研發跨領域女性人才培育計畫-以新藥創新創業為例
8/1/22 → 7/31/23
Project: A - Government Institution › d - Ministry of Education
-
Development of Natural Product and Its Derivatives as Potential Treatment for Alzheimer’S Disease(2/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
研發新穎性MAPK8抑制劑並探討其抗癌功效及作用機轉
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
研發急性骨髓性白血病的新穎性CDK8抑制劑並以毒理測試評估其安全性
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Li, M. C., Coumar, M. S., Lin, S. Y., Lin, Y. S., Huang, G. L., Chen, C. H., Lien, T. W., Wu, Y. W., Chen, Y. T., Chen, C. P., Huang, Y. C., Yeh, K. C., Yang, C. M., Kalita, B., Pan, S. L., Hsu, T. A., Yeh, T. K., Chen, C. T. & Hsieh, H. P., Feb 2023, In: Journal of Medicinal Chemistry. 66, 4, p. 2566-2588 23 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer
Chang, C. D., Chao, M. W., Lee, H. Y., Liu, Y. T., Tu, H. J., Lien, S. T., Lin, T. E., Sung, T. Y., Yen, S. C., Huang, S. H., Hsu, K. C. & Pan, S. L., 2023, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 38, 1, 2166039.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Identification and analysis of a selective DYRK1A inhibitor
Lin, T. E., Chao, M. W., HuangFu, W. C., Tu, H. J., Peng, Z. X., Su, C. J., Sung, T. Y., Hsieh, J. H., Lee, C. C., Yang, C. R., Pan, S. L. & Hsu, K. C., Feb 2022, In: Biomedicine and Pharmacotherapy. 146, 112580.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach
Yen, S. C., Chen, L. C., Huang, H. L., HuangFu, W. C., Chen, Y. Y., Eight Lin, T., Lien, S. T., Tseng, H. J., Sung, T. Y., Hsieh, J. H., Huang, W. J., Pan, S. L. & Hsu, K. C., Apr 2022, In: Bioorganic Chemistry. 121, p. 105675 105675.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia
Yen, S. C., Wu, Y. W., Huang, C. C., Chao, M. W., Tu, H. J., Chen, L. C., Lin, T. E., Sung, T. Y., Tseng, H. J., Chu, J. C., Huang, W. J., Yang, C. R., HuangFu, W. C., Pan, S. L. & Hsu, K. C., Jun 2022, In: Phytomedicine. 100, 154061.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)
Datasets
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
HuangFu, W. (Creator), Sung, T. (Creator), Lee, Y. (Contributor), Pan, S. (Creator), Cheng, Y. (Creator), Chang, F. (Creator), Wei, P. (Contributor), Huang, C. (Contributor), Huang, H. (Contributor) & Cheng, C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
Dataset
-
Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach
Chao, M. (Creator), Lin, T. E. (Creator), HuangFu, W. (Creator), Chang, C. (Creator), Tu, H. (Creator), Chen, L. (Creator), Yen, S. (Creator), Sung, T. (Creator), Huang, W. (Creator), Yang, C. (Creator), Pan, S. (Creator) & Hsu, K. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13213424.v1, https://tandf.figshare.com/articles/dataset/Identification_of_a_dual_TAOK1_and_MAP4K5_inhibitor_using_a_structure-based_virtual_screening_approach/13213424/1
Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chang, L. (Contributor), Liou, J. (Creator), Lai, M. (Contributor), Chang, C. (Contributor), Tu, H. (Contributor), Chao, M. (Contributor), Pan, S. (Contributor), Chen, Y. (Creator) & Teng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://doi.org/10.6084%2Fm9.figshare.8202902.v1
Dataset
-
Additional file 1 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Cheng, Y. (Creator), Cheng, C. (Creator), HuangFu, W. (Creator), Pan, S. (Creator), Sung, T. (Creator), Chang, F. (Creator), Huang, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor) & Lee, Y. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228278.v1, https://doi.org/10.6084%2Fm9.figshare.14228278.v1
Dataset
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M. (Contributor), Chang, L. (Contributor), Tu, H. (Contributor), Chang, C. (Contributor), Lai, M. (Contributor), Chen, Y. (Creator), Liou, J. (Creator), Teng, C. (Contributor) & Pan, S. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4522856.v1, https://springernature.figshare.com/collections/Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/4522856/1
Dataset